Thyme Care at a glance
As of- [1] Latest valuation: CNBC, September 4, 2026
- [2] Equity raised: Sum of the 1 sourced equity round in the funding history below (debt, tender offers and rumored rounds excluded), September 4, 2026
- [3] Lead investors: CNBC, September 4, 2026
Is this your company? Get featured or correct your listing →
Recent changes
- Sep 4, 2026Sep 4, 2026Raised $125M Series E at a $2 billion valuation CNBC
- Sep 4, 2026Sep 4, 2026First reported valuation: $2 billion CNBC
- Sep 4, 2026Sep 4, 2026Thyme Care Doubles to $2B on Cancer Navigation Pulse story
Funding history
1 equity event · newest first · sources dated per row| Date | Round | Amount | Valuation | Lead investors | Source |
|---|---|---|---|---|---|
| Sep 4, 2026 | Series E | $125M | $2 billionpost-money | Morgan Healthunverified | CNBCPulse story |
Equity only. “Equity raised” above sums the rounds with a dated, linked source; rumored rounds, tender offers and secondary sales are listed but not counted, and debt financing is listed separately.
Investors
Latest Pulse
- Sep 8, 2026This Week Showed AI Funding's Two Speeds at OnceStoke Space and Mistral raised a combined $4.2 billion this week while Sapien and NavigateAI, two real vertical-AI companies with paying customers, raised a combined fraction of that -- the same split Pulse has tracked in AI money all year.→
- Sep 7, 2026The Application Layer Is Where I'd Be Writing ChecksNearly $5 billion went into three compute-layer companies in a single week while the software built on top of that compute raised a fraction of it -- and the compute bets are credit trades wearing venture clothes.→
- Sep 6, 2026Why AI Compute Swallowed the Week's Venture DollarsCrusoe, Fluidstack and Gimlet Labs closed $4.8 billion between them in five days, and every dollar landed in the layer between the chips and the models rather than in the applications built on top.→
- Sep 4, 2026Thyme Care Doubles to $2B on Cancer NavigationMorgan Health led a $125 million Series E with Humana and CVS Health Ventures joining, as the Nashville company's oncology navigation service reached 135,000 actively treated patients.→
Coverage Timeline
newest firstAll Coverage
Related Companies
Same sector
Thyme Care FAQ
What is Thyme Care's valuation?
Thyme Care was last valued at $2 billion in its September 2026 Series E, according to CNBC (September 4, 2026).
How much has Thyme Care raised?
Thyme Care has raised at least $125M in equity across 1 sourced funding round tracked by Value Add VC. The most recent was a $125M Series E in September 2026 at a $2 billion post-money valuation, reported by CNBC. Debt financing, tender offers and secondary sales are not counted.
Who invested in Thyme Care?
Lead investors in Thyme Care's sourced funding rounds include Morgan Health. Per round: its September 2026 Series E was led by Morgan Health.
Sources & methodologyshow
Where these figures come from
- CNBCmajor outlet2 facts
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.